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Plasma progesterone levels remain elevated through-
out human pregnancy, suggesting that reduced repro-
ductive-tract progesterone receptor (PR) initiates la-
bor. Placental abruption and excess thrombin
generation elicit preterm delivery (PTD). PR, gluco-
corticoid receptor (GR), and total and p-ERK1/2 in
decidual cells (DCs) and interstitial trophoblasts (IT)
were assessed via immunohistochemical staining
in abruption-associated PTD versus gestational-age
matched control placentas, and in cultured DCs incu-
bated with estradiol (E2)  medroxyprogesterone ac-
etate (MPA)  thrombin. Immunostaining for PR was
lower in DC nuclei in abruption versus control decidua
and was absent from ITs; GR was higher in IT than DCs,
with no abruption-related changes in either cell type;
p-ERK1/2 was higher in DCs in abruption than control
decidua, with total ERK 1/2 unchanged. Immunoblotting
of cultured DCs demonstrated strong E2, weak MPA, and
intermediate E2MPA mediated elevation of PR-A and
PR-B levels, with constitutive GR expression. In cultured
DCs, thrombin inhibited PR but not GR mRNA levels, re-
duced PR binding toDNA and [3H]progesterone binding to
PR, and enhanced phosphorylated but not total ERK1/2
levels. Coincubation with a specific p-ERK1/2 inhibitor
reversed thrombin-enhanced p-ERK1/2 and lowered PR
levels. Thus, abruption-associated PTD is initiated by func-
tional progesterone withdrawal, as indicated by signifi-
cantly reduced DC nuclear expression of PR-A and PR-B.
Functional withdrawal of progesterone results in in-
creased p-ERK1/2, and is thus one pathway initiating
2138abruption-associated PTD. (Am J Pathol 2012, 181:
2138–2148; http://dx.doi.org/10.1016/j.ajpath.2012.08.036)
During human pregnancy, bleeding into the decidua basa-
lis (abruption) can occur either as a concealed abruption or
as vaginal bleeding or retrochorionic hematoma formation.
Vaginal bleeding in more than one trimester is associated
with a sevenfold increased risk of preterm premature rup-
ture of the membranes (PPROM).1–3 The association be-
tween abruption and PPROM is particularly strong between
22 and 32 weeks. During this period, abruption occurs in
37.5% of PPROM cases, compared with 0.8% of patients
with term delivery (P  0.01).4 Ischemic placental dis-
eases associated with pre-eclampsia and idiopathic fetal
growth restriction also accompany half of all preterm
deliveries (PTDs), with or without abruption.1 The primary
defect in these cases is shallow endovascular tropho-
blast invasion of the decidua resulting in impaired remod-
eling of the spiral arteries.1,5 Other placental lesions as-
sociated with abruption include spiral artery thrombosis4
and sclerotic lesions in myometrial arteries.6 Inherited
thrombophilias also appear to be linked to abruption.7
Women experiencing an abruption face long-term health
risks.8
During the luteal phase of the human menstrual cycle,
progesterone (P4) stimulates estradiol (E2)-primed hu-
man endometrial stromal cells to decidualize and ex-
press tissue factor (TF),9 a transmembrane 45-kDa glyco-
protein. Vascular injury initiates clotting as a consequence
of binding of plasma-derived factor VII to perivascular cell
membrane-bound TF. The resulting TF/VIIa complex pro-
motes hemostasis by cleaving prothrombin to thrombin,
which converts fibrinogen to fibrin and activates platelets to
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decidual cell (DC)-expressed TF prevents hemorrhage,
initially as blastocyst-derived endovascular trophoblasts
breach decidual capillaries,11 subsequently during pla-
centation as endovascular trophoblasts mediate decid-
ual arterial remodeling,12 and finally during the third
stage of labor to prevent puerperal hemorrhage.13
In human term decidua, immunoreactive TF levels are
highest in DCs, whereas adjacent interstitial trophoblasts
(ITs) are virtually devoid of TF immunostaining.13 The
thrombin-generating potential of decidual TF is reflected
in the profound hypofibrinogenemia and disseminated
intravascular coagulation accompanying severe placen-
tal abruption.14 The strong association between decidual
TF-induced thrombin generation and prematurity is evi-
dent in the high predictive value of elevated circulating
thrombin-antithrombin complex levels for subsequent oc-
currence of PPROM and PTD.15–17
Previous observations in our laboratory suggest that
decidual thrombin generation plays a pivotal role in
abruption-associated PPROM. Specifically, in vitro
studies demonstrated that thrombin acts via protease-
activated receptor (PAR-1) in cultured term DCs to
induce mRNA and protein expression of matrix metal-
loproteinases 1 and 3 (MMP-1 and -3).18,19 Marked
elevation in levels of both MMPs leads to degradation
of the cellular matrix and is implicated in PPROM and
cervical changes preceding labor.18–20 Thrombin
markedly enhances IL-8 mRNA and protein levels in
term DC cultures.21 We also observed that the decidua
basalis of patients with abruption-induced PPROM in
the absence of clinical evidence of infection contains a
dense aseptic neutrophil infiltrate accompanied by el-
evated levels of interleukin-8 (IL-8), a potent neutrophil
chemoattractant and activator.22 This abruption-asso-
ciated increase in neutrophils colocalized with excess
decidual fibrin deposits, as determined by picro-Mal-
lory staining.21 These in situ observations are consis-
tent with abruption-induced decidual generation of
thrombin, which cleaves fibrinogen to fibrin.
Elevated P4 levels maintain myometrial quiescence
during mammalian pregnancy.23 In most mammals, a
decline in circulating P4 levels triggers parturition. In
humans, however, as well as in some higher primates,
placental P4 production and plasma P4 levels remain
elevated until delivery. This phenomenon suggests that
parturition is induced by functional P4 withdrawal, re-
flecting lower uterine progesterone receptor (PR) lev-
els and/or a shift to dysfunctional PR isoform domi-
nance.24 The clear involvement of excess DC-derived
thrombin generation during abruption, taken together
with our previous demonstration that term parturition is
accompanied by reduced PR expression in DCs,25 led
us to hypothesize that thrombin elicits functional P4
withdrawal during abruption-associated PTD. To ad-
dress this issue, we sued a triple-immunostaining tech-
nique to assess PR expression in DCs and IT at the
maternal-fetal interface in sections from abruption-as-
sociated, in comparison with gestational age-matched
idiopathic PTD decidua basalis sections. This immuno-
staining included the glucocorticoid receptor (GR), be-cause competition between P4 and cortisol for the GR
has been implicated in the onset of parturition.26 Com-
plementing these in situ observations, the effects of
thrombin on PR and GR mRNA and protein expression
and PR activity were evaluated in primary cultures of
leukocyte-free human term DCs.
Nuclear factor B p65 subunit (p65 NF-B), p38 MAP
kinase, and ERK 1/2 are each a well-described intracel-
lular signaling mediator of thrombin effects in other cell
types.27,28First identified as an enhancer binding protein
for immunoglobulin  light chain gene expression in B
cells, NF-B enhances the expression of several mole-
cules that regulate immune responses, inflammation, cell
division, and apoptosis. NF-B is present in an inactive
form in the cytoplasm and is usually comprised of het-
erodimers of p50 and p65 subunits.29,30 Cytoplasmic
NF-B is associated with an inhibitory protein, IB. Ap-
propriate stimulation induces phosphorylation-mediated
disassociation of IB from NF-B. Subsequently, the
NF-B dimer translocates to the nucleus and binds to a
specific DNA sequence to regulate transcription.29
Thrombin-increased IB phosphorylation results in ele-
vated NF-B activity in several cell types.31,32The MAPK
superfamily consists of three well-characterized subfam-
ilies, p38 MAPK, c-Jun N-terminal kinase (JNK) MAPK,
and ERK1/2 MAPK.33 The p38 MAPK and c-Jun N-termi-
nal kinase pathways are activated in response to stress,
resulting in promotion of inflammation and programmed
cell death.34,35 By comparison, ERK1/2 MAPK is acti-
vated by phosphorylation in response to mitogens and
growth factors. After activation, p38, JNK, and ERK1/2
MAPKs are translocated from the cytoplasm to the nu-
cleus.36 Recent studies have demonstrated that thrombin
activates p38 MAPK and ERK1/2 MAPK by increasing
their phosphorylation in several cell types.27,31,32,37,38 In
the present study, with the goal of understanding the
molecular mechanisms underlying these thrombin ef-
fects, in situ and in vitro observations were extended to
assess the involvement of the ERK signaling pathway on
thrombin-mediated PR expression in DCs.
Materials and Methods
Patients and Tissues for Immunohistochemistry
After written informed consent had been received, pla-
cental specimens containing decidua basalis were ob-
tained from patients with abruption-related PTDs (n  7).
Patients with idiopathic PTD served as gestational age-
matched controls (n  7). The gestational age for abrup-
tion-associated PTD specimens (34.5 5.8 weeks, mean
SD; range, 22 to 39.6 weeks) did not differ significantly
from that for control patients (34.9 5.6 weeks; range, 22
to 39.6 weeks). Cases displayed clinical and histological
evidence of abruption, including recurrent vaginal bleed-
ing and evidence of fresh clot formation on the placental
bed and/or decidual hemosiderin deposition or retrocho-
rionic hematoma formation. None of the control patients
showed clinical evidence of abruption (ie, vaginal bleed-
ing, hypofibrinogenemia, decidual hemosiderin, or retro-
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fever or histological chorioamnionitis (ie, 10 neutrophils
per high-power field in the subchorionic space, chorion,
or placental plate based on established criteria39). Both
case and control patients were also without clinical evi-
dence of clinical chorioamnionitis [ie, maternal fever
(37.8°C), uterine tenderness, foul-smelling amniotic
fluid or visualization of pus at the time of the speculum
examination, maternal tachycardia (100 beats/minute),
or fetal tachycardia (160 beats/minute)].40 All proce-
dures were performed at Yale-New Haven Hospital and
were approved by the Yale Human Investigation Commit-
tee (HIC).
Patients and Tissues for DC Cultures
After written informed consent had been received, pla-
centas and attached fetal membranes were obtained un-
der HIC approval from patients (n  8) with uncompli-
cated pregnancies undergoing repeat cesarean deliveries
at term at Yale-NewHaven Hospital. None of the specimens
was obtained from patients in labor (ie,4 contractions per
hour, associated with cervical change). The decidua was
separated from the amniochorion, and a small portion of
the decidua was formalin-fixed and paraffin-embedded
and then examined histologically for signs of underlying
acute and chronic inflammation. The remainder of each
specimen was used to isolate DCs.
Immunohistochemistry
Triple immunostaining was performed to detect either
PR or GR together with vimentin and cytokeratin; single
immunostaining was performed to detect total ERK1/2
or phosphorylated ERK1/2 (p-ERK1/2). Formalin-fixed,
paraffin-embedded sections (5 m thick) were depar-
affinized in xylene and rehydrated through a descend-
ing ethanol series. Antigen retrieval involved boiling
the slides in citrate buffer followed by endogenous
peroxidase quenching with 3% hydrogen peroxide and
blocking with 10% donkey or goat serum (Jackson
ImmunoResearch, West Grove, PA). Serial sections
were incubated overnight at 4°C with mouse monoclo-
nal antibodies (mAbs) against PR (Dako, Carpinteria,
CA) or against GR (R&D Systems, Minneapolis, MN), or
with rabbit polyclonal antibodies (pAbs) against total
ERK1/2 (Biosource; Life Technologies, Carlsbad, CA)
or p-ERK1/2 (pTpY185/187) (Biosource; Life Technol-
ogies). After a wash, slides were incubated with the
appropriate biotinylated secondary antibodies (Vector
Laboratories, Burlingame, CA) and then with a strepta-
vidin-peroxidase complex (Elite ABC kit; Vector Labo-
ratories). After a wash, diaminobenzidine tetrahydro-
chloride dehydrate (DAB; Vector Laboratories) was
used to generate a brown stain for anti-PR, anti-GR,
anti-total ERK1/2, and anti-p-ERK1/2 MAPK antibodies.
Triple-immunostained sections were incubated over-
night with a chicken anti-vimentin pAb (Abcam, Cam-
bridge, MA), then with a secondary antibody (donkey
biotinylated anti-chicken IgG; Jackson ImmunoRe-
search), and then with a streptavidin-alkaline phospha-tase complex (Elite ABC kit; Vector Laboratories) for 30
minutes, and immunostaining was developed using the
Vector Red (Vector Laboratories) for 30 minutes. These
steps were repeated for cytokeratin staining using rabbit
anti-cytokeratin pAb (Abcam), a donkey biotinylated anti-
rabbit IgG (Jackson ImmunoResearch), and a streptavidin-
peroxidase complex (Elite ABC kit) and Vector SG (Vec-
tor Laboratories). For negative controls, appropriate
nonspecific mouse IgG isotypes were used at the same
concentrations as the primary antibodies. Slides were
mounted and evaluated by histological scoring as de-
scribed below (HSCORE Analysis).
Primary DCs grown in Falcon chamber slides (BD Bio-
sciences, Bedford, MA) were subjected to immunofluo-
rescence staining, using a similar protocol as described
above, up to and including the normal goat serum block-
ing stage. After separate overnight incubation with each
of the primary antibodies for PR or p-ERK1/2 or total
ERK1/2 MAPK, the slides were washed three times in
PBS-Tween 20 and then incubated with goat AlexaFluor
568-labeled anti-mouse IgG or anti-rabbit IgG for 30 min-
utes. After a wash, the slides were mounted using
Vectashield mounting medium with DAPI (Vector Labora-
tories).
HSCORE Analysis
The intensity of immunostaining for PR, GR, total ERK1/2,
and p-ERK1/2 was semiquantitatively evaluated using
histological score (HSCORE) analysis and scored as fol-
lows: 0, no staining; 1, weak, but detectable, staining; 2,
moderate staining; and 3, intense staining. For each tis-
sue, an HSCORE value was derived by summing the
percentages of cells that stained at each intensity cate-
gory and multiplying that value by the weighted intensity
of the staining, using the formula
HSCOREi iPi, (1)
where i represents the intensity scores, and Pi is the
corresponding percentage of the cells. In each slide, five
randomly selected areas were evaluated under a light
microscope at 40 magnification.25,41 The HSCORES
were determined at different times by two independent
observers (U.A.K. and W.M.) masked to tissue type and
clinical outcome, and the average score of both observ-
ers was then used as the final HSCORE for each sample.
The intra- and interindividual coefficients of variation were
10% and 13%, respectively.
Experimental Cell Incubations
DCs were isolated as described previously.42 Isolated
decidual cells (5  105 cells/mL) were suspended in
basal medium, a Phenol Red-free 1:1 v/v mix of Dulbec-
co’s modified Eagle’s medium (Invitrogen; Life Technol-
ogies, Carlsbad, CA) and Ham’s F-12 (Flow Laboratories,
Inglewood, CA) with 100 U/mL penicillin, 100 g/mL
streptomycin, and 0.25 g/mL amphotericin B (Fungi-
zone) supplemented with 10% charcoal-stripped calf se-
rum. Confluent leukocyte-free DCs were primed for 7
days in basal medium with charcoal-stripped calf serum
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mol/L of estradiol (E2), or 107 mol/L of medroxyproges-
terone acetate (MPA) (Sigma-Aldrich, St. Louis, MO) or
E2MPA with one change of medium. The cultures were
washed twice with PBS and switched to a serum-free
defined medium (DM) consisting of basal medium with
ITS Premix culture supplement (BD Biosciences, Bed-
ford, MA), 5 mol/L FeSO4, 0.5 mol/L ZnSO4, 1 nmol/L
CuSO4, 20 nmol/L Na2SeO3, trace elements (Life Tech-
nologies), 50 g/mL ascorbic acid (Sigma-Aldrich), and
50 ng/mL epidermal growth factor (BD Biosciences) with
either vehicle or steroids with or without thrombin (Amer-
ican Diagnostic, Greenwich, CT) for 24 hours. A subset of
cultures was incubated with the specific inhibitors
PD98059 (PD, an ERK1/2 MAPK inhibitor), SB203580 (a
p38 MAPK inhibitor), or NF-B activation inhibitor III
(NF-B III) (Calbiochem-EMD; Millipore, San Diego, CA)
for test periods of 15 minutes (short term) and 24 hours
(long term).
After the various test periods, the cells were rinsed in
ice-cold PBS, stored in the dishes at 80°C for several
days, and then lysed with a protease inhibitor cocktail kit
and extraction kit (NE-PER; Thermo Scientific, Rockford,
IL) to extract nuclear and cellular proteins. Conditioned
DM supernatants and cell lysates were stored at 80°C.
Parallel incubations after a 6-hour test period were used
to extract RNA.
Western Blotting
Western blot analysis was performed on nuclear extracts
(50 g/lane from DCs and 8 g/lane from T47D cells, a
positive control for PR and GR; Abcam), which were
subjected to reducing SDS-PAGE on a 7.5% Tris-HCl gel
(Bio-Rad, Hercules, CA). Transfer onto nitrocellulose,
blocking, washing, chemiluminescence, and stripping
were performed as described previously.13 Immunoblot-
ting used an mAb specific for PR-A and PR-B (Dako) and
then incubation with horseradish peroxidase-conjugated
goat anti-mouse IgG (ICN Biomedicals, Aurora, OH). Sig-
nals were developed using a chemiluminescence kit
(Amersham; GE Healthcare, Piscataway, NJ). The mem-
brane was sequentially stripped and reprobed with mAbs
for GR (R&D Systems), and then for TATA-binding protein
(Abcam) for the loading control.
After short-term (15 minutes) incubations of DCs with
thrombin, with and without specific intracellular signal-
ing inhibitors, cells were lysed in 1 SDS sample buf-
fer (100 L/well in a six-well plate) for total protein
extraction and subjected to SDS-PAGE electrophore-
sis. Immunoblotting initially used a rabbit pAb specific
for p-ERK1/2 (pTpY185/187; Biosource; Life Technolo-
Table 1. Primer Sequences Used in Quantitative Real-Time PCR
Gene Sense
ACTB (-actin) 5=-CGTACCACTGGCATCGTGAT-3=
PR 5=-AGCCCTAAGCCAGAGATTCA-3=
GR 5=-CCTAAGGACGGTCTGAAGAGC-3=gies), a rabbit pAb specific for p-p65 NF-B (S276;Cell Signaling Technology, Danvers, MA), or a rabbit
mAb specific for p-p38 MAPK (T180/Y182; Cell Signal-
ing Technology). Membranes were then incubated with
HRP-conjugated goat anti-rabbit IgG (Vector Labora-
tories). Signals were developed using a chemilumines-
cence kit (Amersham; GE Healthcare). Membranes
were sequentially stripped and reprobed with a pAb for
total ERK1/2 (Biosource; Life Technologies), a rabbit
mAb for total p65 NF-B (C22B4; Cell Signaling Tech-
nology), a rabbit pAb for total p38 MAPK (Cell Signal-
ing Technology), and finally a mAb for -actin (Abcam)
used as a loading control.
Quantitative Real-Time RT-PCR
Total RNA was extracted with TRI reagent (Sigma-Al-
drich) according to the manufacturer’s instructions. To
obtain cDNAs, reverse transcription was performed with
1 g of total RNA and a kit using SuperScript II Reverse
Transcriptase (Invitrogen; Life Technologies) in an Ep-
pendorf master cycler (Eppendorf, Westbury, NY). A
quantitative standard curve was created using serial di-
lutions of cDNA. Real-time quantification of PR, GR, and
-actin was determined using SYBR Green master mix
and a LightCycler system (Roche Diagnostics, Indianap-
olis, IN). Melting curve analysis determined the specificity
of the amplified products and the absence of primer-
dimer formation. The primers were synthesized and gel-
purified at the Yale DNA Synthesis Laboratory, Critical
Technologies Program (Table 1).
Electrophoretic Mobility Shift Assay
For electrophoretic mobility shift assay (EMSA), the DCs
were homogenized in solution A (10 mmol/L HEPES-KOH
pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCl2, 0.1 mmol/L
EGTA, 0.5 mmol/L phenylmethylsulfonyl fluoride, and 0.5
mmol/L dithiothreitol) (Bio-Rad). Nuclei were pelleted at
4°C, resuspended in solution B (solution A with 420
mmol/L NaCl, 5% v/v glycerol; Fisher Scientific, Pitts-
burgh, PA), rocked for 30 minutes at 4°C, and then cen-
trifuged at 14,000  g at 4°C for 20 minutes. Supernatant
aliquots were stored at 80°C. Double-stranded DNA
probes with a consensus PR binding site (5=-GATCCTG-
TACAGGATGTTCTAGCTACA-3=) were end-labeled with
32P and incubated with 5 g of nuclear proteins for 30
minutes at 25°C with 0.05 g/L of salmon sperm DNA
(Sigma-Aldrich). Binding specificity was tested in the
presence of 100-fold excess of unlabeled wild-type
probes or unlabeled probes containing a mutation on the
PR binding site. Samples were loaded onto a 6% poly-
acrylamide nondenaturing gel and electrophoresed in
Antisense Size (bp)
5=-GTGTTGGCGTACAGGTCTTTG-3= 452
5=-TAGGATCTCCATCCTAGACC-3= 303
5= GCCAAGTCTTGGCCCTCTAT-3= 4780.5 Tris-borate-EDTA buffer at 4°C for 90 minutes. Au-
. *P 
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probes.
PR Binding Assay
After incubation of DC nuclear proteins at 4°C for 16
hours in 0.5 mL TEMGD buffer consisting of 10 mmol/L
Tris-HCl, pH 7.4, 1.5 mmol/L EDTA, 10% glycerol, 25
mmol/L sodium molybdate, 1 mmol/L dithiothreitol, and 5
nmol/L [3H]P4 (NEN; PerkinElmer, Waltham, MA), bound
and free tracers were separated by adding 0.1 mL ice-
cold, vigorously stirred, dextran-coated charcoal (25 g
Norit A activated charcoal, 250 to 350 mesh; Sigma-
Aldrich) and 2.5 g dextran (Sigma-Aldrich) in 100 mL of
TEMGD buffer (Sigma-Aldrich). Centrifugation at 3000 
g for 10 minutes at 4°C was followed by liquid scintillation
counting of supernatants (LS 6000SC; Beckman Coulter,
Brea, CA). Nonspecific binding was measured in the
presence of 5 mol/L of unlabeled P4; specific binding is
expressed in counts per minute (cpm/ng protein).
Statistical Analysis
Immunostaining HSCOREs for PR and GR and the EMSA
PR/DNA-binding results were normally distributed, and
the results were analyzed by one-way analysis of vari-
ance with post hoc Holm-Šidák test for HSCOREs and
post hoc Tukey test for EMSA data. Quantitative RT-PCR
results were not normally distributed, and therefore pair-
wise multiple comparisons were analyzed with the
Kruskal-Wallis test analysis of variance, followed by the
post hoc Student-Newman-Keuls test. The PR binding
assay results and immunostaining HSCOREs for total and
p-ERK1/2 MAPK were analyzed using a t-test. Control
Figure 1. Immunoreactive PR and GR in DCs (arrows) and ITs (arrowhea
analysis. A–D: Tissues were triple-stained for vimentin (red) to identify DC
localized to DCs, with significantly lower staining in abruption-complicated
abruption-complicated and control specimens. In both control and abruptio
DCs. Numbers in A mark representative examples of staining intensity in ce
PR and GR by cell type (DC versus IT). Data are expressed as means  SEM
7 different patient tissue samples for each group.and treatment groups were compared, with P  0.05representing statistical significance. Statistical calcula-
tions used SigmaStat version 3.0 (Systat Software, San
Jose, CA).
Results
Representative immunostaining for PR, using an antibody
that recognizes both PR-A and PR-B, and for GR in ab-
ruption-complicated and gestational age-matched con-
trol decidual sections are shown in Figure 1. The tissues
were also consecutively stained with the DC marker vi-
mentin and the trophoblast marker cytokeratin, to localize
the cell type expressing PR and GR. Immunoreactive PR
was localized exclusively in DC nuclei in both cases and
controls. Significantly lower PR staining intensity was
found in abruption-complicated decidua, compared with
controls (Figure 1, A and C). The PR HSCORE differed
significantly between abruption and controls (P  0.05)
(Figure 1E). Immunostaining for GR, however, was pref-
erentially localized to ITs in both cases and controls, with
weak staining evident in DCs (Figure 1, B and D). The GR
HSCORE differed significantly between ITs and DCs (P
0.05) (Figure 1E). No differences in the intensity of GR
immunostaining were noted between abruption and con-
trol specimens in either ITs or DCs (Figure 1, B and D).
Negative controls for both PR and GR showed no staining
(data not shown).
The reduced abruption-related immunostaining for PR
prompted examination of thrombin effects on steady-
state PR mRNA levels in leukocyte-free term DC cultures.
Thrombin and MPA each significantly lowered PR mRNA
levels, compared with E2 alone (Figure 2). Inhibition was
greatest in cultures coincubated with both MPA and
thrombin. In contrast, neither MPA nor thrombin signifi-
ontrol and abruption-complicated decidua, with HSCORE staining intensity
ratin (gray) to identify ITs, and brown to identify either PR or GR. PR was
ontrol specimens. GR staining in DCs was low, with no differences between
ens, GR immunostaining was significantly higher in intensity in ITs than in
i : 0, absent; 1, weak; 2, moderate; and 3, intense staining. E: HSCOREs for
0.05, PR in control versus abruption; †P  0.05, GR in DCs versus ITs. n ds) of c
s, cytoke
versus c
n specim
ll nuclecantly affected GR mRNA expression, whether added
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clear extracts indicated that primary term DCs expressed
PR-B bands (116 kDa) and PR-A bands (82 kDa), with
both isoforms greatly enhanced by E2 and to a lesser
extent by MPA alone (Figure 3). Addition of thrombin with
both E2 and MPA markedly reduced both PR isoform
levels; concentration dependence of thrombin inhibition
was clearly evident in coincubations with E2. Unlike the
inhibition of PR expression by thrombin and MPA, a band
migrating with the mobility of GR (94 kDa) was unaltered
by incubation with the steroids or thrombin added sepa-
rately or in combination.
The binding activity of nuclear extracts of term DCs to
DNA probes containing a consensus PR binding site is
shown in Figure 4. Thrombin elicited a concentration-
dependent inhibition of PR in this DNA binding activity
that attained statistical significance at 2.5 U/mL. The
specificity of DNA binding activity is shown in Figure 5.
Basal binding activity was eliminated by including excess
unlabeled (cold) wild-type probe in the reaction, whereas
binding activity was unaffected by adding a similar ex-
cess of a probe containing a mutated PR binding site. In
E2MPA-treated term DCs, 2.5 U/mL of thrombin signif-
icantly decreased nuclear extract specific [3H]PR bind-
ing activity, as determined by a standard steroid receptor
binding assay (Figure 6).
During parallel incubations with E2 or with E2MPA,
used to mimic the steroid milieu of pregnancy, term de-
cidual monolayers expressed both phosphorylated and
total forms of p65 NF-B, p38 MAP kinase, and ERK1/2
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Figure 2. Thrombin effects on PR and GR mRNA levels in DCs. Term DCs
were primed in E2 or E2MPA, then switched to DM with corresponding
steroids  2.5 U/mL thrombin (Th) for 6 hours, as described under Materials
and Methods. RNA was measured by quantitative real-time RT-PCR, for PR
and GR. Values were normalized to -actin mRNA. Data are expressed as
means SEM. *P 0.05 versus E2; †P 0.05 versus E2Th; ‡P 0.05 versus
E2MPA. n  8.(Figure 7A). However, during coincubation of E2MPAwith thrombin, levels of p-ERK1/2 (but not of p-p38 MAPK
or p-p65 NF-B) appear to be elevated, compared with
the respective nonphosphorylated form. Moreover, in co-
incubations of E2MPA, the addition of a specific inhib-
itor for either NF-B activation (NF-B III) or p38 MAPK
activation (SB203580) not only failed to reverse thrombin-
mediated inhibition of PR-A and PR-B expression, but
lowered levels of both PR isoforms further (Figure 7B).
Densitometry confirmed that only p-ERK1/2 was clearly
up-regulated by thrombin (Figure 7).
Western blotting revealed the effects of PD (an ERK1/2
MAPK action inhibitor) in reversing thrombin inhibition of
PR-A and PR-B expression (Figure 8, A and C) and blunt-
ing thrombin induction of phosphorylated but not total
ERK1/2 (Figure 8, B and D) in term DC monolayers.
Compared with E2 alone, PR-A and PR-B levels were
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thrombin, E2, and MPA on levels of immunoreactive PR and GR. Confluent
leukocyte-free DCs were primed for 7 days with vehicle (Control), or 108
mol/L E2, or 107 mol/L MPA or both. Primed DCs were incubated for 24
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fects. Confluent term DCs were incubated with and without thrombin (U/mL)
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AJP December 2012, Vol. 181, No. 6lowered in parallel incubation with E2MPA and lowered
further by thrombin; the latter effect was reversed during
coincubation with PD (Figure 8A). Compared with E2
alone, E2MPA modestly inhibited phosphorylated but
not total ERK1/2 (Figure 8B). Cultures incubated with
E2MPA and thrombin displayed clear up-regulation of
phosphorylated but not total ERK1/2, an effect blocked
by PD. Parallel incubations were performed with E2
alone, to increase the sensitivity of detecting thrombin
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Figure 5. Specificity of DNA binding activity of PRs in nuclear extracts from
control versus Th term DCs. Excess wild-type probe without radiolabel
(100 cold) in the reaction eliminated basal binding activity, but similar
excess of cold probe containing a mutated PR binding site had no effect.
Confluent term DCs were incubated with and without thrombin (2.5 U/mL)
for 24 hours. Electrophoretic mobility shift assays were performed on nuclear
extracts, as described under Materials and Methods. S indicates band shift.
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Figure 6. Effect of thrombin on P4 receptor binding activity in term DCs.
Confluent term DCs were incubated with Th (2.5 U/mL) or without (Control)
for 24 hours. Nuclear extracts were analyzed with a steroid receptor binding
assay. Data are expressed as means  SEM. **P  0.01 Student’s t-test.
n  5.reciprocal effects on PR and p-ERK1/2 expression (Fig-
ure 8, C and D). Thrombin inhibited PR-A and PR-B, and
PD reversed this inhibition (Figure 8C). Furthermore,
thrombin increased expression of phosphorylated but not
total ERK1/2, and the addition of PD reversed thrombin-
mediated up-regulation of p-ERK1/2 (Figure 8D). Densi-
tometry confirmed the Western blot results (Figure 8, C
and D). Thus, compared with the -actin loading control,
thrombin lowered PR-A and PR-B levels and enhanced
p-ERK1/2 versus total ERK1/2, whereas coincubation
with PD reversed both thrombin-inhibited PR expression
and thrombin-augmented p-ERK1/2 expression (Figure
8, C and D).
TheWestern blotting results (Figure 8) were confirmed by
inspection of immunofluorescence staining of term DC
monolayers (Figure 9). Specifically, the immunofluores-
cence data indicated that, in incubations with E2, addition
of thrombin for 24 hours decreased both the staining inten-
Figure 7. Western blot of term DCs showing effects of Thr on activation of
intracellular signaling molecules. A: Confluent leukocyte-free DCs, primed
for 7 days with E2, or E2MPA, were incubated with E2, or E2MPA, or
E2MPAThr (1 U/mL) in DM for 15 minutes. Specific antibodies detected
phosphorylated and total p65 NF-B, phosphorylated and total p38 MAPK,
and phosphorylated and total ERK1/2 MAPK. B: PR levels in cultured term
DCs incubated for 24 hours with E2, or E2MPA, or E2MPAThr (1 U/mL)
with or without NF-B activation inhibitor III (NF-B III; 106 mol/L) or with
or without the p38 MAPK inhibitor SB203580 (SB; 106 mol/L). Densitometry
data derived from arbitrary densitometric readings, using ImageJ software
version 1.45s (NIH, Bethesda, MD), indicated that, in parallel incubations
with E2MPA, only p-ERK1/2 was increased during coincubation with
thrombin (A), and that coincubation with specific inhibitors of NF-B acti-
vation (NF-B III) or p38 MAPK activation (SB203580) further lowered levels
of both PR-A and PR-B (B). Ph-, phosphorylated; T-, total.sity and the number of PR-positive cells, which was re-
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short-term (15 minutes) incubation with thrombin aug-
mented p-ERK1/2, which again was reversed by PD (Figure
9B). In contrast, expression of total ERK1/2 was unaffected
by either thrombin or PD (Figure 9C).
Immunostaining of decidual sections provided in situ
evidence that, at the maternal-fetal interface, p-ERK1/2 is
preferentially enhanced in the nuclei of DCs in abruption
(Figure 10, C and D). By contrast, no such abruption-
associated changes were evident for total ERK1/2, which
stained both nuclei and cytoplasm of DCs (Figure 10, A
and B). Moreover, there were no abruption-related
changes for either total ERK1/2 or p-ERK1/2 in ITs (Figure
10). These findings were confirmed by HSCORES indi-
cating that DCs also display significantly increased
p-ERK1/2 (P  0.05), compared with ITs, in the decidua
of abruption specimens (Figure 10E).
Discussion
The PRs belong to a superfamily of ligand-activated nu-
clear transcription factors comprised of specific domains
that mediate DNA binding, hormone binding, and trans-
activation.43 In target tissues, progestin activation of PR
involves dimerization, phosphorylation, and subsequent
binding to cis-acting P4 response elements on DNA that
modulate activity of target gene promoters. Both PR-A
and PR-B display the same binding affinity for P4, and are
encoded by a single gene under the control of separate
estrogen-sensitive promoters that give rise to distinct
mRNA species.44 Cotransfections with different reporter
Figure 8. Western blotting of term DCs demonstrates thrombin-mediated
effects on ERK1/2 signaling and inhibition of PR isoform expression. A and
B: Confluent leukocyte-free term DCs were incubated with E2 alone or with
MPA, MPAThr, or MPAThrPD in DM for 24 hours (A) or with E2 alone
or with Thr, MPA, MPAThr, or MPAThrPD for 15 minutes (B). Thrombin
concentration, 1 U/mL; ERK1/2 inhibitor PD98059 (PD) concentration, 106
mol/L. C and D: Parallel incubations with thrombin with or without PD were
performed in the presence of E2 but the absence of MPA for 24 hours (C) or
15 minutes (D). Densitometry data derived from arbitrary densitometric
readings, using ImageJ software, indicated reversal of the effects of thrombin
on PR expression (C) and ERK1/2 phosphorylation (D) during coincubation
with PD (E2THRPD). M, molecular weight ladder.constructs in cell lines not normally expressing PR indi-cated that PR-B displays hormone-dependent transacti-
vation, whereas PR-A displays cell-specific and reporter-
specific activity that may be similar to PR-B, or may be
inactive, or may behave as a transdominant PR-B inhib-
itor.45 Moreover, PR-A can affect the transcriptional ac-
tivity of glucocorticoid, mineralocorticoid, androgen, and
estrogen receptors.23
In most mammalian species, a rapid lowering of ma-
ternal P4 levels precedes labor. In humans, however,
maternal, fetal, and amniotic fluid P4 levels remain ele-
vated until delivery. This paradox has fostered the con-
cept (reviewed by Thijssen23) that parturition is initiated
by functional P4 withdrawal, reflecting reduced expres-
sion of PR levels and/or a shift in the ratio of PR isoforms
that result in dominance of dysfunctional PR-A over func-
tional PR-B. The onset of functional P4 withdrawal has been
attributed to local mechanisms that block P4 inhibition of
proparturition autocrine/paracrine effector molecules such
as cyclooxygenase/prostaglandins, proinflammatory cyto-
kines, gap junctions, and MMPs in the myometrium, cervix,
fetal membranes, and/or decidua.46–48
Figure 9. Immunofluorescence staining for thrombin-mediated-regulation
of PR and ERK1/2 MAPK activity in cultured term DCs. Red fluorescence
indicates PR (A), phosphorylated p-ERK1/2 (B), or total ERK1/2 (C) with or
without PD. DAPI (blue) was used as a nuclear counterstain.
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termine whether abruptions are accompanied by func-
tional P4 withdrawal. Use of a primary antibody recogniz-
ing both PR-A and PR-B to perform triple immunostaining
of placental sections demonstrated that, among the ma-
jor resident cell types at the maternal-fetal interface, PR is
localized exclusively in the nuclei of vimentin-positive
DCs. Moreover, DC nuclei in abruption sections dis-
played significantly lower PR HSCOREs, compared with
DC nuclei from gestational age-matched control speci-
mens. Western blotting of nuclear extracts from primary
leukocyte-free term DC cultures complemented these in
situ observations by demonstrating that i) DCs express
both PR-A and PR-B, ii) E2 enhances levels of both iso-
forms, iii) MPA produces a smaller increase in these
Figure 10. Expression of phosphorylated and total ERK1/2 MAPK in DCs
and ITs in decidua of control and abruption-related specimens. Immunore-
active p-ERK1/2 and T-ERK1/2 MAPK in vimentin-positive DCs (arrow-
heads) and cytokeratin-positive ITs (arrows) of control (A and C) and
abruption-complicated (B and D) decidua. A and B: Total ERK1/2 MAPK is
localized in DCs and ITs with similar staining in control (A) and in abruption-
complicated (B) specimens. Inset, A: Isotype control. C and D: In contrast,
expression of p-ERK1/2 in DCs is higher in abruption-complicated decidua
(D), as indicated by increased nuclear staining compared with that of control
decidua (C). E: HSCOREs for p-ERK1/2 by cell type (DC versus IT). Data are
expressed as means  SEM. n  7 different patient tissue samples for each
group.levels, and iv) E2MPA produces intermediate levels ofboth isoforms. These differential steroid responses are
consistent with both the priming action of E2 on endome-
trial PR expression and the sustained expression of PR
within the steroid milieu of pregnancy.49 In coincubations
with E2 or E2MPA, thrombin elicited a concentration-
dependent lowering of PR-A and PR-B levels in the cul-
tured DCs. Other experiments with term DC monolayers
found that thrombin lowered steady-state PR mRNA lev-
els and that thrombin inhibited PR receptor binding to
radiolabeled P4 and reduced binding of PR to its cognate
DNA elements in gel shift assays.
Assessment of PR expression was complemented by
parallel measurements aimed at determining whether al-
tered GR expression contributes to functional P4 with-
drawal. Immunostaining of decidual sections revealed
striking differences between PR and GR expression by
DCs. Unlike the specific immunolocalization of PR in DC
nuclei, immunoreactive GR was observed in nuclei of
both vimentin-positive DCs and cytokeratin-positive ITs.
Significantly higher GR HSCORES were observed in IT
than in DC nuclei, with no significant differences noted
between abruption and control placentas in either cell
type. Complementing these in situ measurements, West-
ern blotting of nuclear extracts from primary leukocyte-
free DC cultures indicated that GR expression is essen-
tially constitutive. Thus, in contrast with highly regulated
PR, the GR mRNA and protein levels were unaffected by
incubation with thrombin or steroids, whether added sep-
arately or together.
Viewed within the context of the present in situ and in
vitro observations linking abruption-related functional P4
withdrawal with thrombin-inhibited PR expression in DCs,
the established association between excess thrombin
and the occurrence of abruptions points to the impor-
tance of identifying any signaling pathway or pathways
mediating this thrombin effect. Thrombin augments the
expression of several biochemical endpoints in different
cell lines and primary cells via phosphorylated ERK1/2 or
p38 MAP kinase or NF-B mediation.27,31,38 However, a
literature search revealed no examples in which thrombin
directly affects the expression of steroid receptors includ-
ing PR and GR.
Seeking to elucidate the mechanism or mechanisms
underlying our novel observation that thrombin inhibits
PR but not GR expression in term DCs, we found that, in
cultured term DCs, thrombin augmented levels of
p-ERK1/2, but not of p-p38 MAP kinase or p-p65 NF-B.
Moreover, inhibition of thrombin-enhanced p-ERK1/2 ex-
pression reversed inhibition of PR-A and PR-B expression
by thrombin. Complementing these in vitro observations,
immunostaining of decidual sections revealed signifi-
cantly elevated levels of phosphorylated but not total
ERK1/2 in DC nuclei of abruption versus gestational age-
matched control specimens, with no such correlation ev-
ident for ITs. Taken together, these in vitro and in situ
observations indicate that thrombin down-regulates de-
cidual PR expression via ERK1/2 phosphorylation.
A recent report from our laboratory indicated that initi-
ation of human labor is accompanied by significantly
reduced immunoreactive PR-A and PR-B levels in decid-
ual cells.25 These observations complement reports that
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ratio of PR-A to PR-B in myometrial cell nuclei induced by
prostaglandins E2 and F2-.50 These effects are ex-
pected to promote functional P4 withdrawal, because
PR-B (but not PR-A) is transcriptionally active in myome-
trial cells.51,52 The present study extends our previous
observations of term labor-related decreased PR-A and
PR-B expression in DCs to abruption-initiated PTD by
demonstrating, first, that immunoreactive PR levels are
significantly lower in DCs of placental sections from ab-
ruption-associated PTD versus gestational age-matched
control placental sections with idiopathic PTD and, sec-
ond, that thrombin, an abruption-related effector mole-
cule generated in excess from DC-expressed TF, directly
inhibits both PR mRNA and PR-A and PR-B protein ex-
pression in DCs via p-ERK1/2. Future studies that deter-
mine whether targeting of myometrial cells by thrombin
inhibits PR expression and/or induces a shift to dysfunc-
tional PR isoform ratio dominance should increase our
understanding of abruption-related functional P4 with-
drawal.
Thrombin, induced by decidual cell TF13 in the setting
of abruption, contributes to PPROM, preterm labor, and
PTD in multiple ways. These include the aforementioned
effects of thrombin on MMP and IL-8 expression in
DCs,18,19 as well augmentation by thrombin of expres-
sion of MMP-9, which preferentially degrades basement
membrane-type proteins in the amniochorion.53 More-
over, direct targeting of human fetal membranes by
thrombin elicits changes consistent with abruption-re-
lated PPROM. Specifically, thrombin directly weakens
preparations of the amniotic membrane, the major load-
bearing fetal membrane component, via induction of tis-
sue remodeling and apoptotic markers.54 Finally, in vitro
and in vivo studies in the rat indicate that exogenous
thrombin or thrombin formed from actively clotting blood
exerts a strong uterotonic action that is independent of
prostaglandin production.55 These observations suggest
a mechanism to explain increased myometrial contrac-
tions in the presence of intrauterine bleeding that is con-
sistent with the onset of preterm labor accompanying
vaginal bleeding.56 Findings from the present study sup-
port the hypothesis that abruption-associated thrombin
generation also initiates progestin withdrawal in the de-
cidua, and thus may be one pathway that either initiates
or contributes to the proparturition effects.
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